Get the Stockscreener App
7.92
4.58%
-0.38
Verrica Pharmaceuticals Inc stock is traded at $7.92, with a volume of 170.59K.
It is down -4.58% in the last 24 hours and up +107.33% over the past month.
Verrica Pharmaceuticals Inc is a dermatology therapeutics company engaged in the development and commercialization of novel treatments that provide a meaningful benefit for people living with skin diseases. Its product candidate, VP-102, is developed for the treatment of molluscum contagiosum, or molluscum, a contagious and pediatric viral skin disease, and common warts.
See More
Previous Close:
$8.30
Open:
$8.41
24h Volume:
170.59K
Relative Volume:
0.45
Market Cap:
$75.16M
Revenue:
$5.12M
Net Income/Loss:
$-67.00M
P/E Ratio:
-5.3878
EPS:
-1.47
Net Cash Flow:
$-38.94M
1W Performance:
-10.10%
1M Performance:
+107.33%
6M Performance:
+17.54%
1Y Performance:
-1.32%
1-Day Range:
$7.88
$8.60
1-Week Range:
$7.82
$9.4989
52-Week Range:
$3.28
$9.8212
Verrica Pharmaceuticals Inc Stock (VRCA) Company Profile
Name
Verrica Pharmaceuticals Inc
Sector
Industry
Phone
484-453-3300
Address
10 NORTH HIGH STREET, WEST CHESTER, PA
Compare VRCA with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
VRCA
Verrica Pharmaceuticals Inc
|
7.92 | 78.77M | 5.12M | -67.00M | -38.94M | -1.47 |
|
VRTX
Vertex Pharmaceuticals Inc
|
452.04 | 113.14B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
741.29 | 78.49B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
877.94 | 54.76B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
397.55 | 54.51B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
INSM
Insmed Inc
|
197.01 | 41.64B | 447.02M | -1.18B | -906.14M | -6.1812 |
Verrica Pharmaceuticals Inc Stock (VRCA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-06-24 | Downgrade | H.C. Wainwright | Buy → Neutral |
| Nov-05-24 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| Jul-25-23 | Upgrade | Needham | Hold → Buy |
| Mar-22-23 | Initiated | Jefferies | Buy |
| Feb-13-23 | Upgrade | RBC Capital Mkts | Sector Perform → Outperform |
| May-25-22 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| May-14-21 | Initiated | RBC Capital Mkts | Outperform |
| Dec-24-20 | Reiterated | H.C. Wainwright | Buy |
| Jul-15-20 | Downgrade | BofA Securities | Buy → Neutral |
| Jun-30-20 | Reiterated | H.C. Wainwright | Buy |
| Jun-24-20 | Initiated | Northland Capital | Outperform |
| Mar-24-20 | Initiated | Needham | Buy |
| Feb-21-19 | Initiated | H.C. Wainwright | Buy |
View All
Verrica Pharmaceuticals Inc Stock (VRCA) Latest News
Armistice Capital LLC Increases Stock Holdings in Verrica Pharmaceuticals Inc. $VRCA - Defense World
Verrica’s $50 Million PIPE Deal Sparks Big Questions About Its Next Growth Phase - MSN
How buybacks impact Verrica Pharmaceuticals Inc. stock value2025 Investor Takeaways & Daily Stock Trend Watchlist - Newser
How Verrica Pharmaceuticals Inc. (1NE) stock performs during market turbulenceJuly 2025 Action & Real-Time Sentiment Analysis - Newser
Why Verrica Pharmaceuticals Inc. (1NE) stock appeals to dividend investorsTrade Risk Assessment & Reliable Price Action Trade Plans - Newser
Will Verrica Pharmaceuticals Inc. (1NE) stock extend growth storyJuly 2025 EndofMonth & Free Low Drawdown Momentum Trade Ideas - Newser
Will Verrica Pharmaceuticals Inc. (1NE) stock benefit from mergersJuly 2025 Review & Safe Capital Investment Plans - Newser
Why analysts recommend Verrica Pharmaceuticals Inc. (1NE) stockJuly 2025 Rallies & Long Hold Capital Preservation Plans - Newser
What market sentiment indicators show for Verrica Pharmaceuticals Inc. (1NE) stockJuly 2025 Price Swings & High Conviction Trade Alerts - Newser
Verrica Pharmaceuticals (VRCA) Stock Analysis Report | Ratings, Financials & Performance - Benzinga
Verrica Pharmaceuticals Stock 5-Day Winning Spree: Stock Climbs 88% - Trefis
Verrica Pharmaceuticals Inc (VRCA) Clearly Signals Buy-Into the Stock: Don’t ignore the signals - Setenews
Latham & Watkins Advises on Verrica Pharmaceuticals’ US$50 Million Private Placement Financing - Legal Desire Media and Insights
Will Verrica Pharmaceuticals Inc. stock pay special dividendsTrade Analysis Summary & High Win Rate Trade Alerts - BỘ NỘI VỤ
Verrica Pharmaceuticals Stock (VRCA) Opinions on $50 Million Financing Deal - Quiver Quantitative
12 Health Care Stocks Moving In Friday's Intraday Session - Sahm
VRCAVerrica Pharmaceuticals Inc Volatility & Greeks - Finviz
Insider Stock Purchases: November 26, 2025 - Quiver Quantitative
Verrica Pharmaceuticals Insider Bought Shares Worth $17,505,157, According to a Recent SEC Filing - marketscreener.com
Verrica Pharmaceuticals announces $50M PIPE financing - MSN
Insider Buying: John Kirby Acquires Shares of Verrica Pharmaceuticals Inc (VRCA) - GuruFocus
[Form 4] Verrica Pharmaceuticals Inc. Insider Trading Activity - Stock Titan
Verrica Pharmaceuticals Executives Make Significant Stock Purchases - TradingView
Officer Rosenberg Buys 2,357 ($10K) Of Verrica Pharmaceuticals Inc [VRCA] - TradingView
CFO Kirby Buys 3,536 ($15K) Of Verrica Pharmaceuticals Inc [VRCA] - TradingView
Caligan Partners LP Significantly Increases Stake in Verrica Pha - GuruFocus
It makes sense and dollars to buy Verrica Pharmaceuticals Inc (VRCA) stock - Setenews
Verrica arranges $50M financing to pay off debt, pursue 'billion-dollar market opportunities' - The Business Journals
Bengal and Assam company an undiscovered gem in small capProtective Put Strategies & Learn the Secrets of Pro Traders - earlytimes.in
Verrica Pharmaceuticals Announces Financing of $50 Million - citybiz
Verrica Pharmaceuticals enters securities purchase agreement with institutional investors - marketscreener.com
Verrica Pharmaceuticals Secures $50M Financing Deal - TipRanks
Verrica Pharmaceuticals stock jumps after $50M financing deal By Investing.com - Investing.com Nigeria
Verrica Pharmaceuticals stock jumps after $50M financing deal - Investing.com India
Verrica Pharmaceuticals (VRCA) Secures $50 Million Through PIPE Deal - GuruFocus
Verrica Pharmaceuticals announces private placement financing of $50 million - TradingView
Verrica Pharmaceuticals (VRCA) Secures $50 Million Through PIPE Financing - GuruFocus
Verrica raises $50 million to repay debt, extend cash runway By Investing.com - Investing.com Canada
[8-K] Verrica Pharmaceuticals Inc. Reports Material Event | VRCA SEC FilingForm 8-K - Stock Titan
Verrica raises $50 million to repay debt, extend cash runway - Investing.com
Verrica Pharmaceuticals Announces Private Placement Financing of $50 Million to Retire Debt and ... - Enidnews.com
Verrica Pharmaceuticals Announces Private Placement - GlobeNewswire
Verrica Pharmaceuticals to Present at Needham Healthcare Conference - MSN
Verrica Pharmaceuticals Inc. announced that it expects to receive $50.067383 million in funding from BKB Growth Investments, LLC and other investors - MarketScreener
Why Verrica Pharmaceuticals Inc. (1NE) stock is a must watch tickerWeekly Gains Report & Risk Adjusted Buy/Sell Alerts - newser.com
Will Verrica Pharmaceuticals Inc. stock maintain growth storyJuly 2025 Breakouts & Expert Approved Momentum Trade Ideas - newser.com
New Cancer Data Hints at a Surgery-Free Future — Verrica’s VP-315 Shows Big Promise - MSN
Verrica Posts Strong Q3 as YCANTH Momentum Builds and Late-Stage Pipeline Advances - MyChesCo
Can Verrica Pharmaceuticals Inc. (1NE) stock deliver consistent EPS growthInsider Buying & Long-Term Capital Growth Strategies - newser.com
How Verrica Pharmaceuticals Inc. (1NE) stock reacts to stronger dollarGold Moves & Short-Term Swing Trade Alerts - newser.com
How forex fluctuations impact Verrica Pharmaceuticals Inc. (1NE) stockJuly 2025 Fed Impact & Smart Money Movement Tracker - newser.com
Verrica Pharmaceuticals Inc Stock (VRCA) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.08%
0.91%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):